Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives

References

• Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y, Kobashi K. (2000). Baicalin, the predominant flavones glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharmacy Pharmacol 52:1563–8.
   PubMed Web of Science ®Google Scholar
• Akao T, Sakashita Y, Hanada M, Goto H, Shimada Y, Teresawa K. (2004). Enteric excretion of baicalein, a flavones of Scutellariae radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2. Pharmaceut Res 21:2120–6.
   PubMed Web of Science ®Google Scholar
• Akao T, Sato K, Hanada M. (2009). Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat. Biol Pharmaceut Bull 32:2079–82.
   PubMed Web of Science ®Google Scholar
• Asimus S, Ashton M. (2009). Artemisinin—a possible CYP2B6 probe substrate? Biopharmaceut Drug Disposit 30:265–75.
   PubMed Web of Science ®Google Scholar
• Cabrera SE, Santos D, Valverde MP, Domínguez-Gil A, Gonzalez F, Luna G, Garcia MJ. (2009). Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients. Antimicrob Agent Chemother 53:2791–8.
   PubMed Web of Science ®Google Scholar
• Chang JH, Yoo P, Lee T, Klopf W, Takao D. (2009). The role of pH in the glucuronidation of raloxifene, mycophenolic acid and ezetimibe. Mol Pharmacol 6:1216–27.
   PubMed Web of Science ®Google Scholar
• Ernstgard L, Johanson G, Karlsson AS, Warholm M. (2007). Phenotyping of cytochrome P450 2E1 in vitro and in vivo. Curr Drug Metab 8:493–8.
   PubMed Web of Science ®Google Scholar
• Fan L, Wang JC, Jiang F, Tan ZR, Chen Y, Li Q, Zhang W, Wang G, Lei HP, Hu DL, Wang D, Zhou HH. (2009). Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation. Eur J Clin Pharmacol 65:403–9.
   PubMed Web of Science ®Google Scholar
• Fan L, Zhang W, Guo D, Tan ZR, Xu P, Li Q, Liu YZ, Zhang L, He TY, Hu DL, Wang D, Zhou HH. (2008). The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Therapeut 83:471–6.
   PubMed Web of Science ®Google Scholar
• Gao R, Zheng Q, Gong T, Fu Y, Deng L, Zhang ZR. (2007). Gradient high-performance liquid chromatography for the simultaneous determination of chlorogenic acid and baicalin in plasma and its application in the study of pharmacokinetics in rats. J Pharmaceut Biomed Anal 43:335–40.
   PubMed Web of Science ®Google Scholar
• Gao Z, Huang K, Yang X, Xu H. (1999). Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochimica Biophysics Acta 1472:643–50.
   PubMed Web of Science ®Google Scholar
• Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S. (2004). Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Disposit 32:314–20.
   PubMed Web of Science ®Google Scholar
• Guo HX, Liu DH, Ma Y, Liu JF, Wang Y, Du ZY, Wang X, Shen JK, Peng HL. (2009). Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacologica Sinica 30:1505–1512.
   PubMed Web of Science ®Google Scholar
• Huang H, Zhang Y, Yang R, Tang X. (2008). Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Tech Biomed Life Sci 874:77–83.
   PubMed Web of Science ®Google Scholar
• Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K, Kishimoto T. (2000). Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55:951–5.
   PubMed Web of Science ®Google Scholar
• Itoh T, itagaki S, Sumi Y, Hirano T, Takemoto I, Iseki K. (2005). Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2. Cancer Chemother Pharmacol 55:420–4.
   PubMed Web of Science ®Google Scholar
• Jang SI, Kim HJ, Hwang KM, Jekal SJ, Pae HO, Choi BM, Yun YG, Kwon TO, Chung HT, Kim YC. (2003). Hepatoprotective effect of baicalin, a major flavones from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 25:585–94.
   PubMed Web of Science ®Google Scholar
• Jeong EJ, Liu Y, Lin H, Hu M. (2005). Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10. Drug Metab Disposit 33:785–94.
   PubMed Web of Science ®Google Scholar
• Kim YH, Jeong DW, Paek IB, Ji HY, Kim YC, Sohn DH, Lee HS. (2006). Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and wogonin in rat plasma. J Chromatogr B Analyt Tech Biomed Life Sci 844:261–7.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Honda M, Yoshizaki H, Yamamoto S, Nakane H, Fukushima M, Ono K, Tokunga T. (1998). Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res 37:131–40.
   PubMed Web of Science ®Google Scholar
• Kotani A, Kojima S, Hakamata H, Kusu F. (2006). HPLC with electrochemical detection to examine the pharmacokinetics of baicalin and baicalein in rat plasma after oral administration of a Kampo medicine. Analyt Biochem 350:99–104.
   PubMed Web of Science ®Google Scholar
• Lai MY, Hsiu SL, Chen CC, Hou YC, Chao PD. (2003). Urinary pharmacokinetics of baicalein, wogonin, and their glycosides after oral administration of Scutellariae radix in humans. Biol Pharmaceut Bull 26:79–83.
   PubMed Web of Science ®Google Scholar
• Lai MY, Hsiu SL, Hou YC, Tsai SY, Chao PD. (2004). Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis. Planta Medica 70:132–7.
   PubMed Web of Science ®Google Scholar
• Lai MY, Hsiu SL, Tsai SY, Hou YC, Chao PD. (2003). Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J Pharmacy Pharmacol 55:205–9.
   PubMed Web of Science ®Google Scholar
• Lau YY, Huang Y, Frassetto L, Benet LZ. (2007). Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Therapeut 81:194–204.
   PubMed Web of Science ®Google Scholar
• Lee H, Kang R, Hahn Y, Yang Y, Kim SS, Cho SH, Chung SI, Yoon Y. (2009). Antiobesity effect of baicalin involves the modulations of proadipogenic and antiadipogenic regulators of the adipogenisis pathway. Phytother Res 23:1615–23.
   PubMed Web of Science ®Google Scholar
• Levesque E, Benoit-Biancamano MO, Delage R, Couture F, Guillemette C. (2008). Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. Pharmacogenomics 9:869–79.
   PubMed Web of Science ®Google Scholar
• Liu L, Deng YX, Liang Y, Pang XY, Liu XD, Liu YW, Yang JS, Xie L, Wang GJ. (2010). Increased oral AUC of baicalin in streptozotocin-induced diabetic rats due to the increased activity of intestinal beta-glucuronidase. Planta Medica 76:70–5.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang X, Li J, Liu R, Shu L, Jin J. (2009). Effects of labrasol on the corneal drug delivery of baicalin. Drug Del 16:399–404.
   PubMed Web of Science ®Google Scholar
• Lu T, Song J, Huang F, Deng Y, Xie L, Wang G, Liu X. (2007). Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang-Lian-Jie-Du-Tang to rats. J Ethnopharmacol 110:412–18.
   PubMed Web of Science ®Google Scholar
• Noe J, Portmann R, Brun ME, Funk C. (2007). Substrate-dependent drug–drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1:OATP2B1:and OATP1B3. Drug Metab Disposit 35:1308–14.
   PubMed Web of Science ®Google Scholar
• Oswald S, Konig J, Lutjohann D, Giessmann T, Kroemer HK, Rimmbach C, Rosskopf D, Fromm MF, Siegmund W. (2008). Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenet Gen 18:559–68.
   PubMed Web of Science ®Google Scholar
• Qiu F, He ZG, Li HZ. (2003). HPLC analyses and pharmacokinetic studies of baicalin and oxymatrine in rabbits. Pharmazie 58:616–19.
   PubMed Web of Science ®Google Scholar
• Ran X, Liang Q, Luo G, Liu Q, Pan Y, Wang B, Pang C. (2006). Simultaneous determination of geniposide, baicalin, cholic acid and hyodeoxycholic acid in rat serum for the pharmacokinetic investigations by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Tech Biomed Life Sci 842:22–7.
   PubMed Web of Science ®Google Scholar
• Rao N, Dvorchik B, Sussman N, Wang H, Yamamoto K, Mori A, Uchimura T, Chaikin P. (2008). A study of the pharmacokinetic interaction of istradefylline, a novel therapeutic for Parkinson’s disease, and atorvastatin. J Clin Pharmacol 48:1092–98.
   PubMed Web of Science ®Google Scholar
• Shen YC, Chiou WF, Chou YC, Chen CF. (2003). Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 465:171–81.
   PubMed Web of Science ®Google Scholar
• Shieh DE, Liu LT, Lin CC. (2000). Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 20:2861–5.
   PubMed Web of Science ®Google Scholar
• Srinivas NR. (2009). Efflux transporter-mediated interactions with atorvastatin—interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin. J Clin Pharmacol 49:1492–3.
   PubMed Web of Science ®Google Scholar
• Taiming L, Xueha J. (2006). Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharmaceut Sci 95:1326–33.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhu H, Zhang Y, Huang C. (2006). Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography. Biomed Chromatogr 20:1116–19.
   PubMed Web of Science ®Google Scholar
• Tang YJ, Zhou FW, Luo ZQ, Li XZ, Yan HM, Wang MJ, Huang FR, and Yue SJ. (2009). Multiple therapeutic effects of adjunctive baicalin therapy in experimental bacterial meningitis. Inflammation [DOI:10.1007/s10753-009-9172-9].
   PubMed Web of Science ®Google Scholar
• Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, Hassan HE, Syed SS, Prisinzano TE, Eddington ND. (2009). Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. Eur J Pharmaceut Biopharmaceut 72:471–7.
   PubMed Web of Science ®Google Scholar
• Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. (2008). Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 108:363–74.
   PubMed Web of Science ®Google Scholar
• Treiber A, Schneiter R, Hausler S, Stieger B. (2007). Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Disposit 35:1400–7.
   PubMed Web of Science ®Google Scholar
• Tsai PL, Tsai TH. (2004). Pharmacokinetics of baicalin in rats and its interactions with cyclosporine A, quinidine and SKF-525A: a microdialysis study. Planta Medica 70:1069–74.
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Raunio H, Pelkonen O. (2006). The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. Curr Drug Metab 7:705–14.
   PubMed Web of Science ®Google Scholar
• Waisundara VY, Hsu A, Tan BK, Hunag D. (2009). Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabet Metab Res Rev 25:671–7.
   PubMed Web of Science ®Google Scholar
• Xing J, Chen X, Sun Y, Luan Y, Zhong D. (2005). Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharmacy Pharmacol 57:743–50.
   PubMed Web of Science ®Google Scholar
• Xing J, Chen X, Zhong D. (2005). Absorption and enterohepatic circulation of baicalin in rats. Life Sci 78:140–6.
   PubMed Web of Science ®Google Scholar
• Xiping Z, Guanghua F, Jinxian H, Weihog W, Rujun X, Wei Z, Jing Y, Qijun Y, Meijuan Y, Qing W, Lini F. (2009a). Baicalin protects thymus of rats with severe acute pancreatitis. Inflammation [DOI:10.1007/s10753-009-9169-4].
   Web of Science ®Google Scholar
• Xiping Z, Hua T, Jie Z, Li C, Yang C, Bei L, Qijun Y, Jing Y, Wengqin Y, Ninnin Z. (2009b). Influence of baicalin on TNF-alpha mRNA, caspase-3 and P-selectin expression in pancreatic tissue if rats with severe acute pancreatitis. Indian J Gastroenterology 28:131-5.
   Google Scholar
• Yi L, Jian-Ping G, Xu X, Lixin D. (2006). Simultaneous determination of baicalin, rhein and berberine in rat plasma by column-switching high-performance liquid chromatography. J Chromatogr B Analyt Tech Biomed Life Sci 838:50–5.
   PubMed Web of Science ®Google Scholar
• Yue J, Peng R, Chen J, Liu Y, Dong G. (2009). Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats. Pharmaceut Res 59:112–19.
   Google Scholar
• Zhang DM, Lu HY, Xie L, Liu XD. (2007). Effect of baicalin and berberine on transport of nimodipine on primary cultured, rat brain the microvascular endothelial cells. Acta Pharmacol Sinica 28:573–8.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Chang Q, Zuo Z. (2005). Role of intestinal first-pass metabolism of baicalin in its absorption process. Pharmaceut Res 22:1050–8.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tain H, Wu C, Ye Q, Jiang X, Chen L, Cai Y, Xu R, Yuan W. (2009). Effect of baicalin on inflammatory mediatory levels and microcirculation disturbance in rats with severe acute pancreatitis. Pancreas 38:732–8.
   PubMed Web of Science ®Google Scholar
• Zhiyan J, Zhengzhong B, Liange J, Shujie Z, Kai D, Hao C, Yongbin Y, Ping L. (2010). Ocular pharmacokinetic study on baicalin in lens of rabbits following intragastric administration. Graefes Archiv Clin Exp Opthalmol 248:59-63.
   Google Scholar
• Zhou QM, Wang S, Zhang H, Lu YY, Wang XF, Motoo Y, Su SB. (2009). The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol Sinica 30:1648–58.
   PubMed Web of Science ®Google Scholar